Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 23, 2004
Screening for lung cancer--a reviewTomasz Kuzniar, Gregory A Masters, Daniel W RaySurgical Oncology Clinics of North America|November 24, 2019
Precision Medicine in Lung Cancer TreatmentDhaval R Shah, Gregory A MastersDelaware Medical Journal|May 2, 2018
Successful Therapy with Nivolumab in Metastatic Renal Cell Carcinoma After Multiple Prior TreatmentsNicole C Finelli, Sarim A Baig, Gregory A MastersSurgical Oncology Clinics of North America|March 5, 2013
Multimodality approach to management of stage III non-small cell lung cancerAnthony Scarpaci, Priya Mitra, Doraid Jarrar, et al.Delaware Medical Journal|March 4, 2005
Primary osteosarcoma of the breastJason T Sperberg, J Wesley Clayton, Gregory A MastersCureus|May 30, 2019
A Case Report of the Clinico-radiologic Challenges of Assessing Treatment Response after Stereotactic Radiation of Oligometastases Preceded by Immunotherapy: Pseudoprogression, Mixed Response Patterns, and Opportunities for Precision RadiationArif S Rashid, Sriram Venigalla, Michael Dzeda, et al.Medical Oncology (Northwood, London, England)|April 1, 2003
Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumorsGregory A Masters, Bruce E Brockstein, Sridhar Mani, et al.Chest|January 16, 2003
Chemotherapeutic management of stage IV non-small cell lung cancerMark A Socinski, David E Morris, Gregory A Masters, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancerGregory A Masters, Elizabeth A Hahn, Daniel H Shevrin, et al.Clinical Lung Cancer|February 20, 2008
Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancerDavid Cella, David Eton, Thomas A Hensing, et al.Pageof 5